A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension

Summary

A multicenter, randomized, double-blind, phase 3 study to evaluate efficacy and safety of HCP1803 compared to RLD2001-1 in patients with essential hypertension

Timeline

Start

2024-03-25

Primary completion

2024-12-02

Completion

2024-12-02

Publications

• Sung KC, Park K, Kim DH, Lim SW, Hong SJ, Lee JB, Ryu DR, Kim SH, Kim MC, Kim NY, Parati G, Rhee MY; HM-APOLLO 301 and 302 Trials Investigators. Single-Pill Low-Dose Triple Combination Therapy vs Standard-Dose Monotherapy in Patients With Mild-to-Moderate Hypertension. J Am Coll Cardiol. 2026 May 12;87(18):2392-2411. doi: 10.1016/j.jacc.2025.12.028. Epub 2026 Feb 11.

Drugs

Indications